Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report
Authors
Keywords
Pasireotide, Pegvisomant, Acromegaly, Cotreatment, Resistant
Journal
BMC Endocrine Disorders
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-24
DOI
10.1186/s12902-018-0231-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- Pegvisomant in acromegaly: an update
- (2017) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pasireotide: a novel treatment for patients with acromegaly
- (2016) Maria Fleseriu et al. Drug Design Development and Therapy
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
- (2011) Yasemin Tutuncu et al. Pituitary
- Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
- (2010) Laurence Katznelson JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
- (2008) N. Karavitaki et al. CLINICAL ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin agonists for treatment of acromegaly
- (2007) Anat Ben-Shlomo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More